Header Logo

Connection

Ira Targoff to Child

This is a "connection" page, showing publications Ira Targoff has written about Child.
Connection Strength

0.514
  1. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006 Nov; 54(11):3682-9.
    View in: PubMed
    Score: 0.044
  2. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 02 23; 62(SI2):SI226-SI234.
    View in: PubMed
    Score: 0.034
  3. Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):235-245.
    View in: PubMed
    Score: 0.033
  4. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Rheumatology (Oxford). 2022 07 06; 61(7):2969-2977.
    View in: PubMed
    Score: 0.032
  5. Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis. Rheumatology (Oxford). 2021 05 14; 60(5):2134-2145.
    View in: PubMed
    Score: 0.030
  6. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology (Oxford). 2021 04 06; 60(4):1839-1849.
    View in: PubMed
    Score: 0.030
  7. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020 04 06; 22(1):69.
    View in: PubMed
    Score: 0.028
  8. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019 07; 78(7):988-995.
    View in: PubMed
    Score: 0.026
  9. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford). 2018 11 01; 57(11):1956-1963.
    View in: PubMed
    Score: 0.025
  10. Medications received by patients with juvenile dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):513-522.
    View in: PubMed
    Score: 0.024
  11. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018 05; 77(5):714-719.
    View in: PubMed
    Score: 0.024
  12. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Arthritis Care Res (Hoboken). 2017 07; 69(7):1088-1094.
    View in: PubMed
    Score: 0.023
  13. Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography. Pediatr Rheumatol Online J. 2016 Nov 29; 14(1):64.
    View in: PubMed
    Score: 0.022
  14. Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis. Arthritis Rheumatol. 2016 Mar; 68(3):761-8.
    View in: PubMed
    Score: 0.021
  15. Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2014 May; 66(5):732-40.
    View in: PubMed
    Score: 0.018
  16. Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):1969-75.
    View in: PubMed
    Score: 0.018
  17. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jul; 92(4):223-243.
    View in: PubMed
    Score: 0.017
  18. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jan; 92(1):25-41.
    View in: PubMed
    Score: 0.017
  19. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.
    View in: PubMed
    Score: 0.012
  20. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 2006 Nov; 54(11):3670-81.
    View in: PubMed
    Score: 0.011
  21. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.
    View in: PubMed
    Score: 0.006
  22. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997 Jul; 40(7):1257-66.
    View in: PubMed
    Score: 0.006
  23. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996 Oct; 23(10):1794-7.
    View in: PubMed
    Score: 0.005
  24. Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody. J Rheumatol. 1995 Apr; 22(4):762-5.
    View in: PubMed
    Score: 0.005
  25. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum. 1994 Oct; 37(10):1534-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.